The effects on ketogenesis and lipolysis of a norepinephrine (0.04 μg/kg-min), epinephrine (0.04 μg/kg-min), or saline infusion were examined in the overnight-fasted, conscious dog. Plasma insulin and glucagon levels were maintained constant by means of a somatostatin infusion (0.8 μg/kg-min) and intraportal replacement infusions of insulin and glucagon. In saline-infused dogs, plasma epinephrine (62 ± 8 pg/ml), norepinephrine (92 ± 29 pg/ml), blood glycerol (87 ± 10μM), and plasma nonesterified fatty acid (NEFA) (0.82 ± 0.17 mM) levels did not change. Total blood ketone body levels tended to rise (62 ± 10 to 83 ± 11 μM) by 3 h as did total ketone body production (1.5 ± 0.4 to 2.2 ± 0.4 (μmol/kg-min) over the same time interval. Norepinephrine infusion to produce plasma levels of 447 ± 86 pg/ml caused a sustained 50% rise in glycerol levels (66 ± 17 to 99 ± 15 μmol/L, P < 0.05) and 53% rise in nonesterified fatty acids (0.53 ± 0.07 to 0.81 ± 0.15 μmol/L, P < 0.05). Total ketone body levels rose by 43% (51 ± 8 to 73 ± 10 μmol/L) and ketone body production rose by a similar proportion (1.5 ± 0.2 to 2.2 ± 0.3 μmol/kg-min), changes that did not differ significantly from control animals. A similar increment in plasma epinephrine levels (75 ± 15 to 475 ± 60 pg/ml) caused glycerol levels to rise by 82% (105 ± 23 to 191 ± 26 (μmol/L) in 30 min, but this rise was not sustained and the level fell to 146 ± 14 (μmol/L by 120 min. Plasma nonesterified fatty acids rose from a basal value of 0.89 ± 0.19 mM to 1.25 ± 0.29 mM during the first 30 min, but fell to 0.60 ± 0.12 mM by 2 h. Ketone body levels remained unchanged (66 ± 10 μmol/L) and ketone body production declined (1.5 ± 0.3 to 1.0 ± 0.2 μmol/kgmin). These data indicate that (1) although the sustained increase in lipolysis caused by norepinephrine was greater than that caused by fasting alone, the ketogenic responses were not different, and (2) epinephrine has a transient lipolytic effect and an antiketogenic effect compared with controls.
Skip Nav Destination
Article navigation
Original Contributions|
May 01 1985
Regulation of Ketogenesis by Epinephrine and Norepinephrine in the Overnight-fasted, Conscious Dog
Kurt E Steiner;
Kurt E Steiner
Department of Physiology, Vanderbilt University Medical School
Nashville, Tennessee
Search for other works by this author on:
Howard Fuchs;
Howard Fuchs
Department of Physiology, Vanderbilt University Medical School
Nashville, Tennessee
Search for other works by this author on:
Phillip E Williams;
Phillip E Williams
Department of Physiology, Vanderbilt University Medical School
Nashville, Tennessee
Search for other works by this author on:
Ralph W Stevenson;
Ralph W Stevenson
Department of Physiology, Vanderbilt University Medical School
Nashville, Tennessee
Search for other works by this author on:
Alan D Cherrington;
Alan D Cherrington
Department of Physiology, Vanderbilt University Medical School
Nashville, Tennessee
Search for other works by this author on:
K G M M Alberti
K G M M Alberti
Department of Clinical Chemistry and Metabolic Medicine, University of Newcastle, Newcastle-upon-Tyne
United Kingdom
Search for other works by this author on:
Address reprint requests to Dr. K. E. Steiner, Department of Physiology, Vanderbilt University Medical School, Nashville, Tennessee 37232.
Diabetes 1985;34(5):425–432
Article history
Received:
May 17 1984
Revision Received:
October 08 1984
PubMed:
3886459
Citation
Kurt E Steiner, Howard Fuchs, Phillip E Williams, Ralph W Stevenson, Alan D Cherrington, K G M M Alberti; Regulation of Ketogenesis by Epinephrine and Norepinephrine in the Overnight-fasted, Conscious Dog. Diabetes 1 May 1985; 34 (5): 425–432. https://doi.org/10.2337/diab.34.5.425
Download citation file:
63
Views